• 10baggerbamm OP : as a follow-up this is where you use options because you know exactly the risk going in you know what your loss is going to be.
  unfortunately June of 25 is as far out as the contracts go. buying it out of the money contract and throwing a bid in which there's zero bid is what I'm going to do.. so I'll throw different bids in for a nickel $0, .10, .20 different amounts of contracts.. and see if I get filled
  

  Report

  Reply
  Cancel Reply

• 10baggerbamm OP : additionally if you look at transactions in December you have acquisitions of stock by four parties within the company three are 60,000 shares one is 190,000 shares.
  as they say people sell stock for variety of reasons but they buy stock for only one.

  Report

  Reply
  Cancel Reply

• 10baggerbamm OP : 11/11/2024 - 04:01 PM
  SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug (IND) application, ARCT-2304, a self-amplifying mRNA (sa-mRNA) vaccine candidate for active immunization to prevent pandemic influenza disease caused by H5N1 virus. The clinical study is funded by Biomedical Advanced Research and Development Authority (BARDA) and designed to enroll approximately 200 healthy adults in the United States.

  Report

  Reply
  Cancel Reply

• 10baggerbamm OP :

  Report

  Reply
  Cancel Reply

• 10baggerbamm OP : https://expose-news.com/2024/12/18/self-replicating-vaccine-trial-in-the-usa/

  Report

  Reply
  Cancel Reply

View more comments...